Participants who gave away more money scored significantly lower on cognitive tests known to be sensitive to Alzheimer’s disease than those who gave less, a USC study finds.
Grant from the National Institute on Aging will fund research on the role that blood vessel dysfunction plays in the development of dementia and Alzheimer’s disease.
The findings could provide potential targets for new Alzheimer’s drugs.
Research adds to evidence that healthier pre-industrial lifestyles may hold clues to preventing Alzheimer’s and other dementias.
By studying the APOE4 gene and its impact on brain inflammation and metabolism of fatty acids, Hussein Yassine discovers potential new ways to prevent cognitive decline.
After watching his twin brother lose a 15-year fight with the memory-robbing illness, Dan Epstein decided to do something about it. The result: an unprecedented research collaboration between USC and UC San Diego.
Among older Americans surveyed in the weeks after FDA approval of aducanumab, few could correctly answer true or false questions about the first new Alzheimer’s drug in decades.
A transformative donation from the Epstein Family Foundation will accelerate Alzheimer’s research at the two universities in a push to find better treatments and a cure.
Year in review: Whether they’re working with patients, test tubes or massive databases, USC scientists continue to push the envelope with discoveries that are literally changing people’s lives.
Mouse study of human stroke medication reveals potential defense against Alzheimer’s disease and other forms of dementia.
Studying neural stem cells could shed light on how environmental aspects interact with genetic risk factors for dementia, says University Professor Caleb Finch.
The psychiatry and neuroscience chair at the Keck School of Medicine of USC and director of the California Alzheimer’s Disease Center at USC discusses the role of medication in Alzheimer’s treatment.
Researchers say their studies on air pollution and cognitive decline — one involving humans and one with mice — provide evidence that cleaner air may reduce risk for Alzheimer’s and other dementias.
More assistance is needed for the estimated 11 million people caring for loved ones with dementia, USC experts say.
More than 90 federal grants totaling $92 million were awarded to USC researchers in 2020, underscoring the university’s status as one of the nation’s leading research centers as we acknowledge World Alzheimer’s Day 2021.
Fine particle pollution may be one reason why Black women have double the risk of developing Alzheimer’s than white women, new research from the Keck School of Medicine of USC suggests.
Experts from the USC Leonard Davis School of Gerontology share what they’ve learned from years of studying Alzheimer’s disease.
A newly approved yet controversial drug, in particular, brings both hope and challenges for patients and clinicians.
A new USC study may have unlocked therapy options to slow cognitive impairment in people with the APOE4 gene, which has long been associated with Alzheimer’s disease.
A grant from the National Institutes of Health will allow the Han Research Lab to study the link between financial decision-making and Alzheimer’s disease.
You might find a hangover cure, protection against Alzheimer’s and much more in nature’s bounty.
Using MRIs and machine learning, USC researchers mapped comparable degenerative changes in both gray and white matter of the brain.
New disease-modifying treatments would help Medicaid avoid paying $186 billion from 2021 to 2040, a new USC study has found.
High levels of fine particle pollution are associated with brain shrinkage patterns common in Alzheimer’s disease, a USC study finds.